OBJECTIVE: Data from electronic healthcare records (EHR) can be used to monitor drug safety, but in order to compare and pool data from different EHR databases, the extraction of potential adverse events must be harmonized. In this paper, we describe the procedure used for harmonizing the extraction from eight European EHR databases of five events of interest deemed to be important in pharmacovigilance: acute myocardial infarction (AMI); acute renal failure (ARF); anaphylactic shock (AS); bullous eruption (BE); and rhabdomyolysis (RHABD). DESIGN: The participating databases comprise general practitioners' medical records and claims for hospitalization and other healthcare services. Clinical information is collected using four different disease terminologies and free text in two different languages. The Unified Medical Language System was used to identify concepts and corresponding codes in each terminology. A common database model was used to share and pool data and verify the semantic basis of the event extraction queries. Feedback from the database holders was obtained at various stages to refine the extraction queries. MEASUREMENTS: Standardized and age specific incidence rates (IRs) were calculated to facilitate benchmarking and harmonization of event data extraction across the databases. This was an iterative process. RESULTS: The study population comprised overall 19 647 445 individuals with a follow-up of 59 929 690 person-years (PYs). Age adjusted IRs for the five events of interest across the databases were as follows: (1) AMI: 60-148/100 000 PYs; (2) ARF: 3-49/100 000 PYs; (3) AS: 2-12/100 000 PYs; (4) BE: 2-17/100 000 PYs; and (5) RHABD: 0.1-8/100 000 PYs. CONCLUSIONS: The iterative harmonization process enabled a more homogeneous identification of events across differently structured databases using different coding based algorithms. This workflow can facilitate transparent and reproducible event extractions and understanding of differences between databases.
OBJECTIVE: Data from electronic healthcare records (EHR) can be used to monitor drug safety, but in order to compare and pool data from different EHR databases, the extraction of potential adverse events must be harmonized. In this paper, we describe the procedure used for harmonizing the extraction from eight European EHR databases of five events of interest deemed to be important in pharmacovigilance: acute myocardial infarction (AMI); acute renal failure (ARF); anaphylactic shock (AS); bullous eruption (BE); and rhabdomyolysis (RHABD). DESIGN: The participating databases comprise general practitioners' medical records and claims for hospitalization and other healthcare services. Clinical information is collected using four different disease terminologies and free text in two different languages. The Unified Medical Language System was used to identify concepts and corresponding codes in each terminology. A common database model was used to share and pool data and verify the semantic basis of the event extraction queries. Feedback from the database holders was obtained at various stages to refine the extraction queries. MEASUREMENTS: Standardized and age specific incidence rates (IRs) were calculated to facilitate benchmarking and harmonization of event data extraction across the databases. This was an iterative process. RESULTS: The study population comprised overall 19 647 445 individuals with a follow-up of 59 929 690 person-years (PYs). Age adjusted IRs for the five events of interest across the databases were as follows: (1) AMI: 60-148/100 000 PYs; (2) ARF: 3-49/100 000 PYs; (3) AS: 2-12/100 000 PYs; (4) BE: 2-17/100 000 PYs; and (5) RHABD: 0.1-8/100 000 PYs. CONCLUSIONS: The iterative harmonization process enabled a more homogeneous identification of events across differently structured databases using different coding based algorithms. This workflow can facilitate transparent and reproducible event extractions and understanding of differences between databases.
Authors: Richard Platt; Marcus Wilson; K Arnold Chan; Joshua S Benner; Janet Marchibroda; Mark McClellan Journal: N Engl J Med Date: 2009-07-27 Impact factor: 91.245
Authors: Kristen M Moore; April Duddy; M Miles Braun; Richard Platt; Jeffrey S Brown Journal: Pharmacoepidemiol Drug Saf Date: 2008-12 Impact factor: 2.890
Authors: Cristina Varas-Lorenzo; Jordi Castellsague; Mary Rose Stang; Luis Tomas; Jaume Aguado; Susana Perez-Gutthann Journal: Pharmacoepidemiol Drug Saf Date: 2008-08 Impact factor: 2.890
Authors: Paul Avillach; Fleur Mougin; Michel Joubert; Frantz Thiessard; Antoine Pariente; Jean-Charles Dufour; Gianluca Trifirò; Giovanni Polimeni; Maria Antonietta Catania; Carlo Giaquinto; Giampiero Mazzaglia; Gianluca Baio; Ron Herings; Rosa Gini; Julia Hippisley-Cox; Mariam Molokhia; Lars Pedersen; Annie Fourrier-Réglat; Miriam Sturkenboom; Marius Fieschi Journal: Stud Health Technol Inform Date: 2009
Authors: Mette Madsen; Vilmundur Gudnason; Andrzej Pajak; Luigi Palmieri; Evangelista C Rocha; Veikko Salomaa; Susana Sans; Konrad Steinbach; Diego Vanuzzo Journal: Eur J Cardiovasc Prev Rehabil Date: 2007-12
Authors: N Larrañaga; C Moreno; M Basterretxea; P Marín; M D Chirlaque; P Amiano; J Castilla; M Dorronsoro; J R Quirós; M J Sánchez; E Ardanaz; A Barricarte; C Navarro; M J Tormo; C Martínez; T Berenguer; A Agudo; C A González Journal: An Sist Sanit Navar Date: 2009 Jan-Apr Impact factor: 0.829
Authors: Olaf von dem Knesebeck; Markus Bönte; Johannes Siegrist; Lisa Marceau; Carol Link; Sara Arber; Ann Adams; John McKinlay Journal: BMC Health Serv Res Date: 2008-09-29 Impact factor: 2.655
Authors: Martijn J Schuemie; Rosa Gini; Preciosa M Coloma; Huub Straatman; Ron M C Herings; Lars Pedersen; Francesco Innocenti; Giampiero Mazzaglia; Gino Picelli; Johan van der Lei; Miriam C J M Sturkenboom Journal: Drug Saf Date: 2013-10 Impact factor: 5.606
Authors: Gwen M C Masclee; Preciosa M Coloma; Ernst J Kuipers; Miriam C J M Sturkenboom Journal: Am J Gastroenterol Date: 2015-04-28 Impact factor: 10.864
Authors: Vaishali K Patadia; Martijn J Schuemie; Preciosa Coloma; Ron Herings; Johan van der Lei; Sabine Straus; Miriam Sturkenboom; Gianluca Trifirò Journal: Int J Clin Pharm Date: 2014-12-09
Authors: Yuan Luo; William K Thompson; Timothy M Herr; Zexian Zeng; Mark A Berendsen; Siddhartha R Jonnalagadda; Matthew B Carson; Justin Starren Journal: Drug Saf Date: 2017-11 Impact factor: 5.606
Authors: Paul Avillach; Jean-Charles Dufour; Gayo Diallo; Francesco Salvo; Michel Joubert; Frantz Thiessard; Fleur Mougin; Gianluca Trifirò; Annie Fourrier-Réglat; Antoine Pariente; Marius Fieschi Journal: J Am Med Inform Assoc Date: 2012-11-29 Impact factor: 4.497
Authors: Carmen Ferrajolo; Preciosa M Coloma; Katia M C Verhamme; Martijn J Schuemie; Sandra de Bie; Rosa Gini; Ron Herings; Giampiero Mazzaglia; Gino Picelli; Carlo Giaquinto; Lorenza Scotti; Paul Avillach; Lars Pedersen; Francesco Rossi; Annalisa Capuano; Johan van der Lei; Gianluca Trifiró; Miriam C J M Sturkenboom Journal: Drug Saf Date: 2014-02 Impact factor: 5.606